METCALFE DAVID A (Chief Technology Officer) sold 16.7% of their position (32.37K shares) of NEXTGEN HEALTHCARE, INC. on the open market
Open‑market sale worth $666.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/2/2022ACC: 0001209191-22-059451
Officer· Chief Technology Officer
Since Oct 2018
-32.37K
Net shares
Net seller
$666.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20.26K acquired · 52.63K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20.26K
Price / share
$14.07
Trade value
$285K
% of position
11.7%
12/1/2022
173.29K→193.55K
Common Stock
Direct
Shares
−32.37K
Price / share
$20.58
Trade value
$666.13K
% of position
16.7%
12/1/2022
193.55K→161.18K
Total
Net shares
−12.12K
Net value
-$381.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2022 | M · Option Exercise | +20.26K | $14.07 | $285K | 11.7% | 173.29K | 193.55K |
| Common Stock Direct | 12/1/2022 | S · Sale | −32.37K | $20.58 | $666.13K | 16.7% | 193.55K | 161.18K |
| Total | −12.12K | -$381.13K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
20.26K shares
Shares
−20.26K
Strike price
14.07
Held after
87.23K
Exercisable
—
12/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock20.26K shares | 12/1/2022 | M · Option Exercise | −20.26K | 14.07 | — | 87.23K |